Philips Introduces SmartIQ, Reducing Cardiac Imaging Radiation by Over 50%
Philips announced on Monday the launch of SmartIQ, a new imaging technology for its Azurion systems designed to reduce radiation exposure during coronary interventions while maintaining diagnostic image quality.
A Technology Combining Dose Reduction and Image Quality
SmartIQ is based on an ultra-low dose protocol that uses over 50% less X-ray radiation compared to conventional methods. The technology allows for better differentiation of clinical details with enhanced contrast images and reduced background noise.
Clinical Validation and Collaborative Development
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning
✓ Euronext data
✓ AI-powered analysis
Indicative data. No investment advice. Unsubscribe at any time.
SmartIQ was developed in collaboration with leading cardiovascular centers. An initial pilot clinical trial has been published in the Journal of the Society for Cardiovascular Angiography and Interventions (JSCAI), as part of Philips' approach to generating clinical evidence.
Related
